万泰生物 / Wantai Biological

Overview

万泰生物 / Wantai Biological is the publicly listed biotech company controlled within 钟睒睒’s broader business holdings in the episode’s account.

Current Profile

The source uses Wantai primarily to explain why Zhong’s wealth and control story extends beyond beverages. It names the 2020 launch of a domestically developed bivalent HPV vaccine, but it does not provide a full scientific, commercial, or governance profile of the company.

Key Characteristics

• Sits within the wider 养生堂 ownership structure described by the episode.
• Extends Zhong’s controlled assets from consumer products into biotech.
• Is associated in the source with a domestically developed bivalent HPV vaccine launched in 2020.

Evidence

• Ownership context: 风味吃喝：农夫山泉，钟睒睒如何三度问鼎中国首富 identifies Wantai as an A-share company controlled by Yangshengtang.
• Product context: 风味吃喝：农夫山泉，钟睒睒如何三度问鼎中国首富 names the bivalent HPV vaccine 馨可宁 and its 2020 launch.
• Wealth context: 风味吃喝：农夫山泉，钟睒睒如何三度问鼎中国首富 includes the company among the profitable assets supporting Zhong’s wealth ranking.

Qualifications

This source offers only a brief company reference. It does not establish vaccine efficacy, current approvals, financial performance, ownership percentages, or Wantai’s complete product portfolio.

What Changed

• Created a deliberately narrow company profile limited to the episode’s ownership and vaccine context.

Relationships

• 养生堂 - controlling-group relationship described by the source.
• 钟睒睒 - controlling-owner and wealth-profile relationship.
• 农夫山泉 - sister controlled asset in the episode’s portfolio account.
• Cash-Flow-Backed Founder Control - adjacent control pattern, though the source does not detail Wantai’s own financing history.